Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2013 (2013), Article ID 620707, 4 pages
http://dx.doi.org/10.1155/2013/620707
Research Article

Calprotectin Is a Useful Tool in Distinguishing Coexisting Irritable Bowel-Like Symptoms from That of Occult Inflammation among Inflammatory Bowel Disease Patients in Remission

1Department of Gastroenterology, Østfold Hospital Trust, 1603 Fredrikstad, Norway
2Department of Health Sciences, Østfold University College, K.G. Meldahlsvei 9, 1671 Kråkerøy, Norway
3Department of Research, Telemark Hospital Trust, 3710 Skien, Norway
4Institute of Clinical Medicine, University of Oslo-Oslo University Hospital, 0450 Oslo, Norway

Received 19 November 2012; Accepted 17 January 2013

Academic Editor: Peter James Whorwell

Copyright © 2013 Lars-Petter Jelsness-Jørgensen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [19 citations]

The following is the list of published articles that have cited the current article.

  • N. Waugh, E. Cummins, P. Royle, N-B Kandala, D. Shyangdan, R. Arasaradnam, C. Clar, and R. Johnston, “Faecal calprotectin testing for differentiating amongst inflammatory and non-inflammatory bowel diseases: systematic review and economic evaluation,” Health Technology Assessment, vol. 17, no. 55, pp. 1–+, 2013. View at Publisher · View at Google Scholar
  • Vladimir Stanisic, and Eamonn M. M. Quigley, “The overlap between IBS and IBD - what is it and what does it mean?,” Expert Review of Gastroenterology & Hepatology, vol. 8, no. 2, pp. 139–145, 2014. View at Publisher · View at Google Scholar
  • Jan Daebritz, Jason Musci, and Dirk Foell, “Diagnostic utility of faecal biomarkers in patients with irritable bowel syndrome,” World Journal of Gastroenterology, vol. 20, no. 2, pp. 363–375, 2014. View at Publisher · View at Google Scholar
  • Vivian W. Huang, Connie Prosser, Karen I. Kroeker, Haili Wang, Carol Shalapay, Neil Dhami, Darryl K. Fedorak, Brendan Halloran, Levinus A. Dieleman, Karen J. Goodman, and Richard N. Fedorak, “Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-making for IBD Outpatients on Maintenance Infliximab Therapy,” Inflammatory Bowel Diseases, pp. 1, 2015. View at Publisher · View at Google Scholar
  • Jernej Dolinšek, Petra Rižnik, Larisa Sabath, and Dušanka Mičetić-Turk, “Fecal calprotectin as a marker of the severity of mucosal inflammation in children with inflammatory bowel disease,” Wiener klinische Wochenschrift, 2015. View at Publisher · View at Google Scholar
  • Audrey Hastier, Julien Boyer, Marie-Hélène Vivinus, and Thierry Piche, “Irritable bowel syndrome in quiescent inflammatory bowel diseases: Which relationship?,” Hepato-Gastro, vol. 22, no. 10, pp. 929–937, 2015. View at Publisher · View at Google Scholar
  • Paul B. Stoddard, Leyla J. Ghazi, Jade Wong-You-Cheong, Raymond K. Cross, and Fauzia Q. Vandermeer, “Magnetic Resonance Enterography,” Inflammatory Bowel Diseases, vol. 21, no. 1, pp. 229–239, 2015. View at Publisher · View at Google Scholar
  • Chloé Melchior, Moutaz Aziz, Typhaine Aubry, Guillaume Gourcerol, Muriel Quillard, Alberto Zalar, Moïse Coëffier, Pierre Dechelotte, Anne-Marie Leroi, and Philippe Ducrotté, “Does calprotectin level identify a subgroup among patients suffering from irritable bowel syndrome? Results of a prospective study,” United European Gastroenterology Journal, pp. 205064061665006, 2016. View at Publisher · View at Google Scholar
  • K. Diederen, D. R. Hoekman, T. Z. Hummel, T. G. de Meij, B. G. P. Koot, M. M. Tabbers, A. M. Vlieger, A. Kindermann, and M. A. Benninga, “The prevalence of irritable bowel syndrome-type symptoms in paediatric inflammatory bowel disease, and the relationship with biochemical markers of disease activity,” Alimentary Pharmacology & Therapeutics, 2016. View at Publisher · View at Google Scholar
  • Eamonn M. M. Quigley, “Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?,” Therapeutic Advances In Gastroenterology, vol. 9, no. 2, pp. 199–212, 2016. View at Publisher · View at Google Scholar
  • A. D. Lee, B. M. Spiegel, R. D. Hays, G. Y. Melmed, R. Bolus, D. Khanna, P. P. Khanna, and L. Chang, “Gastrointestinal symptom severity in irritable bowel syndrome, inflammatory bowel disease and the general population,” Neurogastroenterology & Motility, 2016. View at Publisher · View at Google Scholar
  • D. Lundgren, J. Rutegård, V. Eklöf, R. Palmqvist, and P. Karling, “Patients with longstanding ulcerative colitis in remission do not have more irritable bowel syndrome-like symptoms than controls,” BMC Gastroenterology, vol. 16, no. 1, 2016. View at Publisher · View at Google Scholar
  • Börje Jonefjäll, Lena Öhman, Magnus Simrén, and Hans Strid, “IBS-like Symptoms in Patients with Ulcerative Colitis in Deep Remission Are Associated with Increased Levels of Serum Cytokines and Poor Psychological Well-being,” Inflammatory Bowel Diseases, vol. 22, no. 11, pp. 2630–2640, 2016. View at Publisher · View at Google Scholar
  • Jung Hwan Oh, “Irritable Inflammatory Bowel Syndrome as a Distinct Disease Entity,” Journal of Neurogastroenterology and Motility, vol. 22, no. 4, pp. 545–546, 2016. View at Publisher · View at Google Scholar
  • Krista M. Reich, Richard N. Fedorak, Karen Madsen, and Karen I. Kroeker, “Role of Vitamin D in Infliximab-induced Remission in Adult Patients with Crohnʼs Disease,” Inflammatory Bowel Diseases, vol. 22, no. 1, pp. 92–99, 2016. View at Publisher · View at Google Scholar
  • Rafiz Abdul Rani, Raja Affendi Raja Ali, and Yeong Yeh Lee, “Irritable bowel syndrome and inflammatory bowel disease overlap syndrome: pieces of the puzzle are falling into place,” Intestinal Research, vol. 14, no. 4, pp. 297, 2016. View at Publisher · View at Google Scholar
  • Stanisław Pieczarkowski, Kinga Kowalska-Duplaga, Przemko Kwinta, Przemysław Tomasik, Andrzej Wędrychowicz, and Krzysztof Fyderek, “Diagnostic Value of Fecal Calprotectin (S100 A8/A9) Test in Children with Chronic Abdominal Pain,” Gastroenterology Research and Practice, vol. 2016, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  • Daniël R. Hoekman, Judith Zeevenhooven, Geert R. D’Haens, and Marc A. Benninga, “The prevalence of irritable bowel syndrome-type symptoms in inflammatory bowel disease patients in remission,” European Journal of Gastroenterology & Hepatology, vol. 29, no. 9, pp. 1086–1090, 2017. View at Publisher · View at Google Scholar
  • Peter R Gibson, “Use of the low-FODMAP diet in inflammatory bowel disease,” Journal of Gastroenterology and Hepatology, vol. 32, pp. 40–42, 2017. View at Publisher · View at Google Scholar